ACRV vs TRMB · $65.1M cap vs P/E 26, rev $1.91B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.
ACRV does not have a complete income-statement cache yet.
Latest reported TRMB revenue for 2026-07-03 was $1.91B. Net income was -$372.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
ACRV currently screens at market cap $65.1M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.
Not investment advice. Open the ACRV and TRMB stock pages for the full models.
Not investment advice.